Diagnostic Capacity of Commercial Extracts vs Prick-by-Prick in the Study of Sensitization to Peanut: Which Technique Should We Use?

J Investig Allergol Clin Immunol. 2020;30(5):373-375. doi: 10.18176/jiaci.0555. Epub 2020 May 6.

Authors

C M D'Amelio¹, A García-Moral², J Bartra^{2

3}, J Azofra⁴, E García Blanca⁵, M D Quiñones⁶, M J Goikoetxea¹, R Martínez-Aranguren¹, G Gastaminza¹

Affiliations

¹ Clínica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.
² Hospital Clínic, Barcelona, Spain.
³ Hospital Clínic, Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
⁴ Hospital Universitario Central de Oviedo, Oviedo, Spain.
⁵ Complejo Hospitalario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
⁶ Hospital Monte Naranco, Oviedo, Spain.

PMID: 32376516
DOI: 10.18176/jiaci.0555

No abstract available

Keywords: Allergy; Commercial extract; Peanut; Prick-by-prick; Skin prick test.

MeSH terms

Adolescent
Adult
Aged
Allergens / immunology*
Arachis / chemistry
Arachis / immunology*
Biomarkers
Child
Female
Humans
Immunization
Immunoglobulin E / blood
Immunoglobulin E / immunology
Male
Middle Aged
Peanut Hypersensitivity / diagnosis*
Peanut Hypersensitivity / immunology*
Plant Extracts / immunology*
Reagent Kits, Diagnostic
Reproducibility of Results
Skin Tests / methods*
Skin Tests / standards
Young Adult

Substances

Allergens
Biomarkers
Plant Extracts
Reagent Kits, Diagnostic
Immunoglobulin E